JPMorgan Downgrades Marathon Petroleum Amid Conference Updates
Marathon Petroleum's Price Target Revision by JPMorgan
Recently, JPMorgan has revised its price target for Marathon Petroleum (NYSE: MPC), lowering it from $172.00 to $171.00, while maintaining a Neutral stance on the stock. This adjustment mirrors a decline in the anticipated third-quarter earnings per share (EPS), now estimated at $0.90 — a notable decrease from the earlier prediction of $2.00. This new estimate also trails the consensus expectation of $2.02.
Factors Influencing Price Target Changes
The recent revisions stem from lower-than-expected refining captures than previously projected. According to JPMorgan, Marathon Petroleum's EBITDA from its refining sector is expected to hit approximately $432 million for the third quarter, a stark contrast to the $1.789 billion reported in the previous quarter. When factoring out turnaround activities, the EBITDA estimate stands at $762 million, showing a decrease from the $1.971 billion achieved earlier. This downturn is primarily attributed to reduced throughput levels and a lower benchmark indicator. The estimated gross margins are forecasted at $14.07 per barrel, down from $17.37 in the prior quarter.
Insight into Operational Performance
JPMorgan projects that Marathon Petroleum’s capture rate should remain stable quarter-to-quarter at about 94% on the MPC indicator. This consistency is worth noting, especially against a backdrop of declining jet fuel cracks, which are offset by secondary product tailwinds owing to reduced prices. Operational expenses are estimated to align with company guidance at approximately $5.34 per barrel.
Throughput Expectations
In terms of throughput, JPMorgan foresees crude throughput to reach around 2,647 thousand barrels per day (kbpd) and overall throughput at 2,847 kbpd, both figures consistent with prior guidance. The midstream sector is also anticipated to maintain its trajectory, with an EBITDA forecast of approximately $1.620 billion, mirroring second-quarter performance.
Recent Developments Affecting Marathon Petroleum
In additional news, Marathon Petroleum is involved in ongoing negotiations regarding a strike at its Detroit refinery, which has persisted without resolution. This strike was initiated by the Teamsters union, with over 200 union members participating, and it poses a potential risk of expanding to other Marathon facilities. The Detroit refinery is significant, processing 140,000 barrels of oil per day and is one of the company’s 13 operational refineries.
Cost Management Strategies
Marathon Petroleum is currently adopting a neutral stance towards cost reductions. A recent report from Piper Sandler has retained its Neutral rating on the company's shares, emphasizing a strategic shift from merely reducing costs to achieving cost competitiveness, aiming for a substantial edge in the market. However, the company, alongside the broader sector, may experiencing near-term margin pressures as it navigates this transition.
Market Reactions to Earnings Reports
On another note, TD Cowen has recently elevated Marathon's stock target to $190 from $187, following the company’s notable earnings beat, attributed to its robust refining operations and significant share buyback initiatives. Last quarter, Marathon generated adjusted earnings per share of $4.12, returning an impressive $3.2 billion to its shareholders. TD Cowen envisions that Marathon Petroleum will sustain a leading distribution yield within its peer group through the fiscal year 2026.
Future Projections and Industry Insights
During its latest earnings call, Marathon Petroleum has forecasted a solid demand for gasoline, diesel, and jet fuel. With global refining capacity growth anticipated to be limited, this scenario is likely to foster a favorable mid-cycle environment for refining activities. The company’s midstream segment, MPLX, is actively pursuing growth avenues and witnessing increased cash flows, fortifying its position in the market.
Frequently Asked Questions
What recent changes did JPMorgan make regarding Marathon Petroleum stock?
JPMorgan revised its price target from $172.00 to $171.00 while maintaining a Neutral stance due to lower earnings estimates.
Why did JPMorgan adjust Marathon's earnings forecast?
The adjustment stems from lower refining margins and captures, alongside reduced throughput expectations for the third quarter.
What impact could the Detroit refinery strike have on Marathon Petroleum?
The ongoing strike may affect operational capacity and productivity, leading to potential supply issues if it expands to other facilities.
How has Marathon Petroleum's stock performed compared to its peers?
Marathon Petroleum has shown robust returns through share buybacks, with a strong earnings report positioning it favorably within its peer group.
What are TD Cowen's expectations for Marathon Petroleum?
TD Cowen raised Marathon's stock target to $190 due to solid operational performance and strong shareholder returns, suggesting a positive outlook.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Essential Class Action Updates for Shareholders of OM, SAGE, SMCI
- Market Dynamics: S&P 500 Reaches New Heights Amid Oil Price Dips
- John Hancock Premium Dividend Fund Achieves New Milestone Amid Growth
- Curtiss-Wright Achieves Record Stock High of $342.36 Amid Growth
- Bonduelle Updates Share Count for Shareholders and Investors
- Arhaus Inc Maintains Steady Ratings Amid Changing Market Dynamics
- HSBC Adjusts Nike's Price Target Amidst Market Challenges
- PIMCO's Insights on U.S. Bond Market Amid Deficit Concerns
- Copenhagen Stock Exchange Sees Small Decline Amid Mixed Trading
- Stocks Rally on Istanbul Exchange Amid Mixed Market Trends
Recent Articles
- Urgent Need for Enhanced Antiviral Research to Combat Pandemics
- Explore the Latest Features in Wijmo 2024 v2 Release
- Citi Begins Neutral Coverage of Old Dominion Freight Line Shares
- BofA Revises Amphenol's Price Target, Holds Neutral Outlook
- Bio-Thera Solutions Partners with Gedeon Richter for BAT2206
- Strategic Deal to Boost Americas Gold and Silver Growth
- Viasat Enhances In-Flight Connectivity Experience for Jets
- WEILAN's BabyAlpha A2 Series: Next-Gen AI FamilyCompanions
- Viking Therapeutics Reveals Positive Drug Trial Outcomes
- Natural Grocers Announces New Store Opening and Hiring Events
- Kymera Therapeutics’ KT-621 Set for Phase 1 Trials in Allergy Treatment
- Sonendo's Strategic Acquisition of Biolase Assets for $14 Million
- Iridium Communications Partners with Nordic for IoT Expansion
- Analysts Weigh In on Google's Antitrust Challenges and Future
- Dragonz Lab Secures $9 Million to Enhance Play-to-Earn Strategy
- Impact of HBO's Satoshi Reveal on Bitcoin: Insights from Dogecoin Founder
- CPI Report Insights: What Investors Need to Know Now
- CIOs Prioritize Network Security Amid Growing AI Risks
- Marinus Pharmaceuticals Shares Innovative Designs for Epilepsy Treatment
- Amprion's $15M Financing Venture to Enhance Neurologic Diagnostics
- Inspiring Advances in Cell and Gene Therapies: Insights Unveiled
- Olema Pharmaceuticals, Inc. Unveils Promising Preclinical Data
- Vizgen and Ultivue Join Forces to Advance Spatial Biology
- Stallion Uranium Secures $2.2 Million Agreement for Future Growth
- Castle Biosciences Enhances Melanoma Treatment with New Insights
- Kymera Therapeutics Marks Milestone with KT-621 Drug Approval
- Veritone Enhances iDEMS for Advanced Public Safety Solutions
- Alnylam Advances Vutrisiran Development for ATTR Disease
- Bird Construction Boosts Dividend by 50% and Outlines Future Goals
- Unlocking Income with High-Yield Dividend Stocks Revealed
- Insights into Stella-Jones Conference Call for Q3 Results
- Zai Lab's Promising Phase 1 Study of ZL-1310 for Lung Cancer
- Exscientia Unveils Promising AI-Designed Drug Data at ENA 2024
- Exciting Developments at ACR Convergence 2024 by Nurix Therapeutics
- D-Wave Showcases Quantum Solutions at 2024 INFORMS Conference
- C4 Therapeutics Showcases Innovations at Key Industry Summit
- Revamping Roadside Assistance: Explore DRIVE Roadside's App
- Marex Group Strengthens FX Capabilities Through Acquisition
- InnoCare's Innovative ICP-488 Shows Promise in Psoriasis Treatment
- Entrada Therapeutics Unveils Promising Duchenne Data at World Muscle Society
- Transformative Collaboration Between Primis and VideoElephant
- QuidelOrtho Strengthens Leadership with New R&D Executive
- Unicycive's UNI-494 Study Marks Major Advancement for Kidney Care
- Flagship Pioneering Welcomes Paul Parker as New Managing Partner
- New Horizons for CareDx: Jing Huang as Chief Data Officer
- Metals Acquisition Limited Celebrates Successful A$150 Million Placement
- Tallinna Sadam Reports Strong Operational Growth for 2024
- Discover Cutting-Edge Heating Solutions at Upcoming Expo
- Glaukos Corporation to Unveil Q3 2024 Financial Insights Soon
- Lithion Partners with Hyundai to Enhance EV Battery Recycling